Diamyd Medical pauses start of Phase III trial
Diamyd Medical has today decided to pause the start of the precision medicine Phase III trial DIAGNODE-3 as well as the initiation of other clinical trials with the diabetes vaccine Diamyd[®] (GAD/alum) pending additional evaluations of the manufacturing process. A new analysis has shown the potential presence of a contamination early in the manufacturing process of the current study drug and Diamyd Medical will evalaute its specific removal before additional clinical work is conducted.“We take this new information seriously and deem it is most prudent to pause the initiation of pending